References
- BorensteinMHedgesLVHigginsJPTRothsteinHRGenerality of the basic inverse-variance methodIntroduction to Meta-AnalysisChichester, UKJohn Wiley & Sons, Ltd2009
- Huedo-MedinaTBSánchez-MecaJMarín-MartínezFBotellaJAssessing heterogeneity in meta-analysis: Q statistic or I2 index?Psychol Methods200611219320616784338
- DerSimonianRLairdNMeta-analysis in clinical trialsControl Clin Trials1986731771883802833
- AlagozGGürelKBayerASerinDCelebiSKuknerSA comparative study of bimatoprost and travoprost: Effect on intraocular pressure and ocular circulation in newly diagnosed glaucoma patientsOphthalmologica20082222889518303228
- ArcieriESSantanaARochaFNGuapoGLCostaVPBlood-aqueous barrier changes after the use of prostaglandin analogues in patients with pseudophakia and aphakia: A 6-month randomized trialArch Ophthalmol2005123218619215710814
- CantorLBHoopJMorganLWuDunnDCatoiraYBimatoprost-Travoprost Study Group. Intraocular pressure-lowering efficacy of bimatoprost 0.03% and travoprost 0.004% in patients with glaucoma or ocular hypertensionBr J Ophthalmol200690111370137316825272
- CantorLBWuDunnDCortesAHoopJKnottsSOcular hypotensive efficacy of bimatoprost 0.03% and travoprost 0.004% in patients with glaucoma or ocular hypertensionSurv Ophthalmol200449Suppl 1S121815016557
- CardasciaNVetrugnoMTrabuccoTCantatoreFSborgiaCEffects of travoprost eye drops on intraocular pressure and pulsatile ocular blood flow: A 180-day, randomized, double-masked comparison with latanoprost eye drops in patients with open-angle glaucomaCurr Ther Res2003647389400
- DirksMSNoeckerRJEarlMRohSSilversteinSMWilliamsRDA 3-month clinical trial comparing the IOP-lowering efficacy of bimatoprost and latanoprost in patients with normal-tension glaucomaAdv Ther200623338539416912020
- GandolfiSSimmonsSTSturmRChenKVanDenburghAMBimatoprost Study Group 3Three-month comparison of bimatoprost and latanoprost in patients with glaucoma and ocular hypertensionAdv Ther200118311012111571823
- HalpernMTCovertDWRobinALProjected impact of travoprost versus both timolol and latanoprost on visual field deficit progression and costs among black glaucoma subjectsTrans Am Ophthalmol Soc200210010911712545683
- KammerJAKatzmanBAckermanSLHollanderDAEfficacy and tolerability of bimatoprost versus travoprost in patients previously on latanoprost: A 3-month, randomised, masked-evaluator, multicentre studyBr J Ophthalmol2010941747919726422
- KozOGOzsoyAYarangumeliAKoseSKKuralGComparison of the effects of travoprost, latanoprost and bimatoprost on ocular circulation: A 6-month clinical trialActa Ophthalmol Scand200785883884317680841
- NetlandPALandryTSullivanEKTravoprost Study GroupTravoprost compared with latanoprost and timolol in patients with open-angle glaucoma or ocular hypertensionAm J Ophthalmol2001132447248411589866
- NoeckerRSDirksMSChoplinNTBernsteinPBatoosinghALWhitcupSMBimatoprost/Latanoprost Study GroupA six-month randomized clinical trial comparing the intraocular pressure-lowering efficacy of bimatoprost and latanoprost in patients with ocular hypertension or glaucomaAm J Ophthalmol20031351556312504698
- NoeckerRJEarlMLMundorfTKSilversteinSMPhillipsMPComparing bimatoprost and travoprost in black AmericansCurr Med Res Opin200622112175218017076978
- NoeckerRJEarlMLMundorfTPeaceJWilliamsRDBimatoprost 0.03% versus travoprost 0.004% in black Americans with glaucoma or ocular hypertensionAdv Ther200320212112812836812
- ParrishRKPalmbergPSheuWPXLT Study GroupA comparison of latanoprost, bimatoprost, and travoprost in patients with elevated intraocular pressure: A 12-week, randomized, masked-evaluator multicenter studyAm J Ophthalmol2003135568870312719078
- VarmaRHwangLJGrundenJWBeanGWInter-visit intraocular pressure range: An alternative parameter for assessing intraocular pressure control in clinical trialsAm J Ophthalmol2008145233634218222194
- AGIS InvestigatorsThe Advanced Glaucoma Intervention Study (AGIS): 7. The relationship between control of intraocular pressure and visual field deteriorationAm J Ophthalmol2000130442944011024415
- HeijlALeskeMCBengtssonBHymanLBengtssonBHusseinMEarly Manifest Glaucoma Trial GroupReduction of intraocular pressure and glaucoma progression: Results from the Early Manifest Glaucoma TrialArch Ophthalmol2002120101268127912365904
- ChauhanBCMikelbergFSBalasziAGLeBlancRPLeskMTropeGECanadian Glaucoma Study: 2. Risk factors for the progression of open-angle glaucomaArch Ophthalmol200812681030103618695095
- Van der ValkRWebersCASchoutenJSZeegersMPHendrikseFPrinsMHIntraocular pressure-lowering effects of all commonly used glaucoma drugs: A meta-analysis of randomized clinical trialsOphthalmology200511271177118515921747
- AptelFCucheratMDenisPEfficacy and tolerability of prostaglandin analogs: A meta-analysis of randomized controlled clinical trialsJ Glaucoma200817866767319092464
- CamrasCBComparison of latanoprost and timolol in patients with ocular hypertension and glaucoma: A six-month masked, multicenter trial in the United States. The United States Latanoprost Study GroupOphthalmology199610311381478628544